drugset / Trial / NCT02555072
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
Phase 4
Active not recruiting
4761 enrolled
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Ministry of Health, Brazil · collab
NaSingle-groupOpen-labelPrevention
Summary
The study main objective is to assess the immune status of children and adults who have never vaccinated, they will receive the first dose of 17DD yellow fever vaccine provided by the study and will be monitored for 10 years. Depending on the results of the analyzed of the data, the period of monitoring may be extended.
Timeline
- Start
- 2016-07
- Primary completion
- 2026-06
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yellow Fever Vaccine | Vaccine | — | — |